Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$116.09 - $227.33 $1.49 Million - $2.92 Million
-12,847 Closed
0 $0
Q1 2022

Sep 21, 2023

SELL
$187.51 - $283.98 $3.22 Million - $4.87 Million
-17,153 Reduced 57.18%
12,847 $2.85 Million
Q1 2022

May 16, 2022

BUY
$187.51 - $283.98 $2.41 Million - $3.65 Million
12,847 New
12,847 $2.85 Million
Q1 2021

May 14, 2021

SELL
$175.6 - $291.43 $5.27 Million - $8.74 Million
-30,000 Closed
0 $0
Q4 2020

Sep 21, 2023

BUY
$174.98 - $272.83 $5.25 Million - $8.18 Million
30,000 New
30,000 $5.25 Million
Q4 2020

Feb 16, 2021

BUY
$174.98 - $272.83 $5.25 Million - $8.18 Million
30,000 New
30,000 $5.25 Million
Q3 2020

Nov 13, 2020

SELL
$185.27 - $238.73 $94,672 - $121,991
-511 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$153.32 - $191.72 $72,367 - $90,491
472 Added 1210.26%
511 $91,000
Q4 2019

Feb 13, 2020

SELL
$134.81 - $177.8 $1.04 Million - $1.38 Million
-7,747 Reduced 99.5%
39 $6,000
Q3 2019

Nov 13, 2019

SELL
$131.82 - $183.4 $3,559 - $4,951
-27 Reduced 0.35%
7,786 $1.05 Million
Q2 2019

Aug 14, 2019

BUY
$124.65 - $167.39 $973,890 - $1.31 Million
7,813 New
7,813 $1.25 Million
Q1 2019

May 15, 2019

SELL
$115.84 - $160.31 $1.69 Million - $2.33 Million
-14,546 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$113.42 - $156.48 $400,712 - $552,843
3,533 Added 32.08%
14,546 $1.78 Million
Q3 2018

Nov 14, 2018

BUY
$121.55 - $156.8 $425,181 - $548,486
3,498 Added 46.55%
11,013 $1.65 Million
Q2 2018

Aug 14, 2018

BUY
$112.2 - $165.95 $843,183 - $1.25 Million
7,515 New
7,515 $1.04 Million
Q4 2017

Feb 14, 2018

SELL
$91.55 - $115.85 $265,495 - $335,965
-2,900 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$79.65 - $90.3 $230,985 - $261,870
2,900
2,900 $262,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.01B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.